Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Neurofibromatosis and lessons for the war on cancer.

Reilly KM.

EMBO Mol Med. 2009 Jul;1(4):198-200. doi: 10.1002/emmm.200900029.

2.

The role of the immune system in neurofibromatosis type 1-associated nervous system tumors.

Karmakar S, Reilly KM.

CNS Oncol. 2017 Jan;6(1):45-60. doi: 10.2217/cns-2016-0024. Epub 2016 Dec 21. Review.

PMID:
28001089
3.

Neurofibromatosis.

McClatchey AI.

Annu Rev Pathol. 2007;2:191-216. Review.

PMID:
18039098
4.

Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1.

Dilworth JT, Kraniak JM, Wojtkowiak JW, Gibbs RA, Borch RF, Tainsky MA, Reiners JJ Jr, Mattingly RR.

Biochem Pharmacol. 2006 Nov 30;72(11):1485-92. Epub 2006 Apr 28. Review.

PMID:
16797490
5.

Neurofibromatosis type 1: modeling CNS dysfunction.

Gutmann DH, Parada LF, Silva AJ, Ratner N.

J Neurosci. 2012 Oct 10;32(41):14087-93. doi: 10.1523/JNEUROSCI.3242-12.2012. Review.

6.

Neurofibromatosis type 1 - a model for nervous system tumour formation?

Rubin JB, Gutmann DH.

Nat Rev Cancer. 2005 Jul;5(7):557-64. doi: 10.1038/nrc1653. Review.

PMID:
16069817
7.

Neurofibromatosis and cancer.

Bader JL.

Ann N Y Acad Sci. 1986;486:57-65. No abstract available.

PMID:
3105405
8.

NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.

Park HJ, Lee SJ, Sohn YB, Jin HS, Han JH, Kim YB, Yim H, Jeong SY.

Int J Oncol. 2013 Feb;42(2):657-66. doi: 10.3892/ijo.2012.1751. Epub 2012 Dec 24.

PMID:
23292448
9.

Recent advances in neurofibromatosis type 1.

Arun D, Gutmann DH.

Curr Opin Neurol. 2004 Apr;17(2):101-5. Review.

PMID:
15021234
10.

[Neurofibromatosis: the most frequent hereditary tumor predisposition syndrome].

Wimmer K.

Wien Med Wochenschr. 2005 Jun;155(11-12):273-80. German.

PMID:
16035388
11.

Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development.

Shin J, Padmanabhan A, de Groh ED, Lee JS, Haidar S, Dahlberg S, Guo F, He S, Wolman MA, Granato M, Lawson ND, Wolfe SA, Kim SH, Solnica-Krezel L, Kanki JP, Ligon KL, Epstein JA, Look AT.

Dis Model Mech. 2012 Nov;5(6):881-94. doi: 10.1242/dmm.009779. Epub 2012 Jul 5.

12.

Neurofibromatosis type 1 (NF1): diagnosis and management.

Ferner RE, Gutmann DH.

Handb Clin Neurol. 2013;115:939-55. doi: 10.1016/B978-0-444-52902-2.00053-9. Review.

PMID:
23931823
13.

New research may help differentiate similar diagnoses.

Levenson D.

Am J Med Genet A. 2010 Feb;152A(2):ix. doi: 10.1002/ajmg.a.33285. No abstract available.

PMID:
20101709
14.

Neurofibromatosis type 1 revisited.

Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL.

Pediatrics. 2009 Jan;123(1):124-33. doi: 10.1542/peds.2007-3204. Review.

PMID:
19117870
15.

Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent manner.

Brown JA, Diggs-Andrews KA, Gianino SM, Gutmann DH.

Mol Cell Neurosci. 2012 Jan;49(1):13-22. doi: 10.1016/j.mcn.2011.08.008. Epub 2011 Aug 26.

16.

A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.

Esposito T, Piluso G, Saracino D, Uccello R, Schettino C, Dato C, Capaldo G, Giugliano T, Varriale B, Paolisso G, Di Iorio G, Melone MA.

J Neurochem. 2015 Dec;135(6):1123-8. doi: 10.1111/jnc.13396. Epub 2015 Nov 12.

17.

Recent developments in neurofibromatosis type 1.

Lee MJ, Stephenson DA.

Curr Opin Neurol. 2007 Apr;20(2):135-41. Review.

PMID:
17351482
18.

The many faces of neurofibromatosis.

Moore BC, Luce J.

Ariz Med. 1982 Feb;39(2):99-102. No abstract available.

PMID:
6803740
19.

The genetic and molecular pathogenesis of NF1 and NF2.

Yohay KH.

Semin Pediatr Neurol. 2006 Mar;13(1):21-6. Review.

PMID:
16818172
20.

Neurofibromatosis type 1: update on a common genetic condition.

Siqveland E, Pond D.

Minn Med. 2009 Mar;92(3):49-52.

PMID:
19400389

Supplemental Content

Support Center